{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:01:16Z","timestamp":1790730076553,"version":"4.1.0"},"reference-count":35,"publisher":"Bioscientifica","issue":"3","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The sodium-iodide symporter (NIS), encoded by the SLC5A5 gene, is essential for iodide uptake and the effectiveness of radioiodide therapy in differentiated thyroid carcinoma (DTC). Data addressing the relationship between NIS transcription and protein expression in pediatric DTC remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of pediatric and adolescent patients with DTC, evaluating NIS protein expression by immunohistochemistry in tumor and adjacent nontumoral thyroid tissues and tumor SLC5A5 mRNA expression by quantitative real-time PCR. Clinical, pathological, molecular, and treatment-related variables were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We analyzed DTC samples from 92 patients diagnosed under the age of 19. NIS was present at significantly lower levels in tumor cells than in adjacent nontumoral cells (odds ratio (OR): 106.8; 95% (CI): 30.7\u2013337.5; P &amp;lt; 0.0001). NIS was only detected in 20\/92 of tumor samples, while SLC5A5 was expressed in 36\/70 of tumor samples. No associations were found between NIS expression or SLC5A5 expression and clinical or histological features, metastasis, iodide-131 (I-131) activity, or treatment response. A dissociation between gene expression and protein detection was observed. Despite reduced tumoral NIS protein expression, most patients achieved an excellent response to radioiodide therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study highlights significant differences in NIS expression between pediatric thyroid tumors and adjacent nontumoral tissue, with a lower proportion of NIS-positive tumors compared with SLC5A5-high cases. No associations were observed between NIS protein detection or SLC5A5 expression and clinical features, histology, tumor aggressiveness, or treatment response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-25-0237","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:31:12Z","timestamp":1777390272000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":1,"title":["Assessing the sodium-iodide symporter (NIS) in pediatric differentiated thyroid carcinoma"],"prefix":"10.1530","volume":"15","author":[{"given":"Paulo Alonso Garcia","family":"Alves-Junior","sequence":"first","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Lucio","family":"Araujo","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Nicolau","family":"Neto","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila","family":"Valverde","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila Coelho Soares","family":"Lima","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Felipe Ribeiro","family":"Pinto","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0156-8274","authenticated-orcid":true,"given":"Janete Maria","family":"Cerutti","sequence":"additional","affiliation":[{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6835-7108","authenticated-orcid":true,"given":"Fernanda","family":"Vaisman","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"2026072110070090600_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1270518","article-title":"Global incidence and prevalence of differentiated thyroid cancer in childhood: systematic review and meta-analysis","volume":"14","author":"Moleti","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026072110070090600_bib2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/genes10090723","article-title":"Thyroid cancer in the pediatric population","volume":"10","author":"Paulson","year":"2019","journal-title":"Genes"},{"key":"2026072110070090600_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/jamaoto.2019.0898","article-title":"Pediatric thyroid cancer incidence and mortality trends in the United States, 1973\u20132013","volume":"145","author":"Qian","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2026072110070090600_bib4","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/ohn.916","article-title":"Pathologic characteristics and surgical outcomes of pediatric versus adult well-differentiated thyroid cancer","volume":"171","author":"Gilja","year":"2024","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2026072110070090600_bib5","doi-asserted-by":"crossref","first-page":"e1670","DOI":"10.1210\/clinem\/dgad343","article-title":"Differentiated thyroid cancers in young adults versus children: clinical characteristics and 10-year follow-up outcomes","volume":"108","author":"Satapathy","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026072110070090600_bib6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1089\/thy.2022.0098","article-title":"Prepubertal children with papillary thyroid carcinoma present with more invasive disease than adolescents and young adults","volume":"33","author":"Thiesmeyer","year":"2023","journal-title":"Thyroid"},{"key":"2026072110070090600_bib7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1515\/JPEM.2011.241","article-title":"Differentiated thyroid carcinoma: presentation and follow-up in children and adolescents","volume":"24","author":"Papendieck","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2026072110070090600_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jpedsurg.2020.07.034","article-title":"Treating papillary and follicular thyroid cancer in children and young people: single UK-center experience between 2003 and 2018","volume":"56","author":"de Jong","year":"2021","journal-title":"J Pediatr Surg"},{"key":"2026072110070090600_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29076","article-title":"Differentiated thyroid carcinoma in children: a retrospective analysis of 125 pediatric cases from a single institution in India","volume":"68","author":"Thankamony","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"2026072110070090600_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"2026072110070090600_bib11","first-page":"15N","article-title":"SNMMI procedure standard\/EANM practice guideline for nuclear medicine evaluation and therapy of differentiated thyroid cancer: abbreviated version","volume":"63","author":"Avram","year":"2022","journal-title":"J Nucl Med"},{"key":"2026072110070090600_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bbamem.2013.08.013","article-title":"The sodium\/iodide symporter: state of the art of its molecular characterization","volume":"1838","author":"Darrouzet","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2026072110070090600_bib13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1590\/S0004-27302007000500004","article-title":"The importance of sodium\/iodide symporter (NIS) for thyroid cancer management","volume":"51","author":"Carvalho","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"2026072110070090600_bib14","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1089\/thy.2020.0826","article-title":"A joint statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the society of nuclear medicine and molecular imaging on current diagnostic and theranostic approaches in the management of thyroid cancer","volume":"31","author":"Gulec","year":"2021","journal-title":"Thyroid"},{"key":"2026072110070090600_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9128754","article-title":"The role of the NIS (SLC5A5) gene in papillary thyroid cancer: a systematic review","volume":"2018","author":"de Morais","year":"2018","journal-title":"Int J Endocrinol"},{"key":"2026072110070090600_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100937","article-title":"Tumor microenvironment affects exogenous sodium\/iodide symporter expression","volume":"14","author":"Castillo-Rivera","year":"2021","journal-title":"Transl Oncol"},{"key":"2026072110070090600_bib17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1203\/00006450-200211000-00021","article-title":"Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents","volume":"52","author":"Patel","year":"2002","journal-title":"Pediatr Res"},{"key":"2026072110070090600_bib18","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1515\/jpem-2020-0201","article-title":"Clinical characteristics, surgical approach, BRAFV600E mutation and sodium iodine symporter expression in pediatric patients with thyroid carcinoma","volume":"33","author":"Castro","year":"2020","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2026072110070090600_bib19","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1089\/thy.2014.0460","article-title":"Management guidelines for children with thyroid nodules and differentiated thyroid cancer","volume":"25","author":"Francis","year":"2015","journal-title":"Thyroid"},{"key":"2026072110070090600_bib20","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-22-0146","article-title":"2022 European Thyroid Association guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma","volume":"11","author":"Lebbink","year":"2022","journal-title":"Eur Thyroid J"},{"key":"2026072110070090600_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.surg.2019.04.076","article-title":"Dual inhibition of BRAF and MEK increases expression of sodium iodide symporter in patient-derived papillary thyroid cancer cells in vitro","volume":"167","author":"Ullmann","year":"2020","journal-title":"Surgery"},{"key":"2026072110070090600_bib22","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.7150\/thno.57689","article-title":"Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS","volume":"11","author":"Oh","year":"2021","journal-title":"Theranostics"},{"key":"2026072110070090600_bib23","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1210\/jc.2007-0353","article-title":"Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining","volume":"93","author":"Sodr\u00e9","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2026072110070090600_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/modpathol.3880305","article-title":"Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer","volume":"14","author":"Ringel","year":"2001","journal-title":"Mod Pathol"},{"key":"2026072110070090600_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1956740","article-title":"Thyroid-specific genes expression uncovered age-related differences in pediatric thyroid carcinomas","volume":"2016","author":"Cordioli","year":"2016","journal-title":"Int J Endocrinol"},{"key":"2026072110070090600_bib26","doi-asserted-by":"crossref","first-page":"E944","DOI":"10.1210\/jc.2013-1450","article-title":"Hypermethylation of a new distal sodium\/iodide symporter (NIS) enhancer (NDE) is associated with reduced NIS expression in thyroid tumors","volume":"99","author":"Galr\u00e3o","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026072110070090600_bib27","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3349\/ymj.2018.59.6.746","article-title":"mRNA expression of SLC5A5 and SLC2A family genes in papillary thyroid cancer: an analysis of the cancer genome atlas","volume":"59","author":"Suh","year":"2018","journal-title":"Yonsei Med J"},{"key":"2026072110070090600_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9440(10)63272-5","article-title":"Evidence for transcriptional and posttranscriptional alterations of the sodium\/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors","volume":"165","author":"Trouttet-Masson","year":"2004","journal-title":"Am J Pathol"},{"key":"2026072110070090600_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/EJE-08-0505","article-title":"Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers","volume":"160","author":"Peyrottes","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2026072110070090600_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1530\/EC-17-0302","article-title":"NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features","volume":"7","author":"Tavares","year":"2018","journal-title":"Endocr Connect"},{"key":"2026072110070090600_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144847","article-title":"NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake","volume":"131","author":"Lee","year":"2021","journal-title":"J Clin Investig"},{"key":"2026072110070090600_bib32","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3390\/cancers11091382","article-title":"Radioiodine-refractory thyroid cancer: molecular basis of redifferentiation therapies, management, and novel therapies","volume":"11","author":"Aashiq","year":"2019","journal-title":"Cancers"},{"key":"2026072110070090600_bib33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1210\/js.2018-00100","article-title":"Implications of Na(+)\/I(\u2212) symporter transport to the plasma membrane for thyroid hormonogenesis and radioiodide therapy","volume":"3","author":"Mart\u00edn","year":"2018","journal-title":"J Endocr Soc"},{"key":"2026072110070090600_bib34","article-title":"Long-term prognostic analysis of children and adolescents with differentiated thyroid carcinoma based on therapeutic response to initial radioiodine therapy","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026072110070090600_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1203\/00006450-200211000-00021","article-title":"Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents","volume":"52","author":"Patel","year":"2002","journal-title":"Pediatr Res"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/15\/3\/ETJ-25-0237.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/15\/3\/ETJ-25-0237.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0237\/520094\/etj-25-0237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0237\/520094\/etj-25-0237.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:07:10Z","timestamp":1784642830000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/15\/3\/ETJ250237\/77604\/Assessing-the-sodium-iodide-symporter-NIS-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-25-0237","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"article-number":"ETJ250237"}}